OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 therapeutics: Challenges and directions for the future
Philip C. Robinson, David Liew, Helen Tanner, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 15
Open Access | Times Cited: 142

Showing 26-50 of 142 citing articles:

Influence of glycosylation on the immunogenicity and antigenicity of viral immunogens
Maddy L. Newby, Joel D. Allen, Max Crispin
Biotechnology Advances (2023) Vol. 70, pp. 108283-108283
Open Access | Times Cited: 10

Bioprotective Respirator Assembled by Defective Carbon Nitride for Long‐Term Light Triggered Health Protection
Zhenxing Zeng, Qi Zhang, Fei Ye, et al.
Advanced Science (2024) Vol. 11, Iss. 31
Open Access | Times Cited: 3

Recent Trends in Lateral Flow Immunoassay With Optical Nanoparticles
Jaehi Kim, Minsup Shin, Jonghyun Shin, et al.
(2023)
Open Access | Times Cited: 9

Serum TGF‐β as a predictive biomarker for severe disease and fatality of COVID‐19
Stefan Frischbutter, Pawel Durek, Mario Witkowski, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 10
Open Access | Times Cited: 9

Vibrio parahaemolyticus: Exploring its Incidence in Malaysia and the Potential of Streptomyces sp. as an Anti-Vibrio Agent
Ke‐Yan Loo, Loh Teng‐Hern Tan, Jodi Woan‐Fei Law, et al.
Progress In Microbes & Molecular Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 9

Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access
Wesley Greenblatt, Charu Gupta, Jennifer L. Kao
Health Affairs (2023) Vol. 42, Iss. 3, pp. 424-432
Open Access | Times Cited: 8

Suramin inhibits SARS-CoV-2 nucleocapsid phosphoprotein genome packaging function
Irene Boniardi, Angela Corona, J. Basquin, et al.
Virus Research (2023) Vol. 336, pp. 199221-199221
Open Access | Times Cited: 8

An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic
Edi Dharmana, Juliane Brun, Michelle L. Hill, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 354-354
Open Access | Times Cited: 8

Microfluidic-assisted single-cell RNA sequencing facilitates the development of neutralizing monoclonal antibodies against SARS-CoV-2
Ziwei Wang, Amelia Siqi Huang, Lingfang Tang, et al.
Lab on a Chip (2024) Vol. 24, Iss. 4, pp. 642-657
Open Access | Times Cited: 2

Unravelling Insights into the Evolution and Management of SARS-CoV-2
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
BioMedInformatics (2024) Vol. 4, Iss. 1, pp. 385-409
Open Access | Times Cited: 2

The Impact of COVID-19 on Amputation and Mortality Rates in Patients with Acute Limb Ischemia: A Systematic Review and Meta-Analysis
Lelio Crupi, Alessio Ardizzone, Fabrizio Calapai, et al.
Diseases (2024) Vol. 12, Iss. 4, pp. 74-74
Open Access | Times Cited: 2

The role of platelets, neutrophils and endothelium in COVID-19 infection
Emanuela Falcinelli, Eleonora Petito, Paolo Gresele
Expert Review of Hematology (2022) Vol. 15, Iss. 8, pp. 727-745
Closed Access | Times Cited: 12

SARS-CoV-2 pandemics: An update of CRISPR in diagnosis and host–virus interaction studies
Wenfang Tang, Anh-Tu Tran, Ling‐Yu Wang, et al.
Biomedical Journal (2023) Vol. 46, Iss. 2, pp. 100587-100587
Open Access | Times Cited: 7

Triterpene Derivatives as Potential Inhibitors of the RBD Spike Protein from SARS-CoV-2: An In Silico Approach
Mayra Avelar, Laura Pedraza‐González, Adalgisa Sinicropi, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2333-2333
Open Access | Times Cited: 7

COVIDpro: Database for Mining Protein Dysregulation in Patients with COVID-19
Fangfei Zhang, Augustin Luna, Tingting Tan, et al.
Journal of Proteome Research (2023) Vol. 22, Iss. 9, pp. 2847-2859
Open Access | Times Cited: 7

Peptidomimetic Small-Molecule Inhibitors of 3CLPro Activity and Spike–ACE2 Interaction: Toward Dual-Action Molecules against Coronavirus Infections
Filomena Tedesco, Lorenzo Calugi, Elena Lenci, et al.
The Journal of Organic Chemistry (2022) Vol. 87, Iss. 18, pp. 12041-12051
Open Access | Times Cited: 10

Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43
Avinash Mali, Gianluigi Franci, Carla Zannella, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1621-1621
Open Access | Times Cited: 5

Dietary Supplement Consumption and Mental Health in Indonesian Adults During Second Wave of COVID-19 Pandemic
Junaidah Yusof, Annette d’Arqom, Amalia Putri Andriani, et al.
Patient Preference and Adherence (2023) Vol. Volume 17, pp. 1799-1811
Open Access | Times Cited: 5

Heart-on-a-chip model of immune-induced cardiac dysfunction reveals the role of free mitochondrial DNA and therapeutic effects of endothelial exosomes
Rick Xing Ze Lu, Naimeh Rafatian, Yimu Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5

Wnt3a Facilitates SARS-CoV-2 Pseudovirus Entry into Cells
Ivonne Melano, Hui‐Jye Chen, Loveness Ngwira, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 217-217
Open Access | Times Cited: 5

Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece
Marios Spanakis, Πέτρος Ιωάννου, Sotiris Tzalis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 7172-7172
Open Access | Times Cited: 9

Advanced oxidation processes for degradation of pharmaceuticals used during COVID-19 pandemic
Irwing M. Ramírez-Sánchez, Ezrah Mariam, Ajay Kumar, et al.
Elsevier eBooks (2024), pp. 337-362
Closed Access | Times Cited: 1

Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes
Aung Khine Linn, Suwimon Manopwisedjaroen, Phongthon Kanjanasirirat, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1427-1427
Open Access | Times Cited: 1

Clindamycin Derivatives: Unveiling New Prospects as Potential Antitumor Agents
Yiduo Jia, Yinmeng Zhang, Hong Zhu
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 276-276
Open Access | Times Cited: 1

Scroll to top